Effect of prolactin on lymphocyte activation from systemic lupus erythematosus patients

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 157-165

  Chavez Rueda, Karina ^a   Legorreta Haquet, Victoria Ma ^a   Cervera Castillo, Hernando ^b   Sánchez, Lourdes ^b   Jara, Luis Javier ^c   Zenteno, Edgar ^d   Chavez Sanchez, Luis ^a   Blanco Favela, Francisco ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c Hospital Especialidades C M La Raza   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Prolactin; SLE; T cell activation

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CD69 ANTIGEN; MESSENGER RNA; MITOGENIC AGENT; PROLACTIN; PROLACTIN RECEPTOR;

ADULT; ANTIGEN EXPRESSION; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERPROLACTINEMIA; LYMPHOCYTE ACTIVATION; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROLACTIN RELEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34948836216     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.018     Document Type: Conference Paper

References (36)

1. TAN, E.M., A.S. COHEN & J.F. FRIES. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
2. BONBARDIER, C., D. GLADMAN, M. UROWITZ, et al. 1992. The Committee on Prognosis Studies in SLE: derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 35: 630-640.
3. BLANCO, F.J.K. & D.A. ISENBERG. 1991. Analysis of antibodies to RNA in patients with systemic lupus erythematosus and other autoimmune rheumatic disease. Clin. Exp. Immunol. 86: 66-70.
4. BLANCO, F., J. KALSI, R. RAVIRAJAN, et al. 1992. IgG subclasses in systemic lupus erythematosus and other rheumatic disease. Lupus 1: 391-399.
5. KELSOE, G. 1996. The germinal center. A crucible for lymphocytes selection. Semin. Immunol. 8: 179-184.
6. DING, L., J.M. GREEN, C.B. THOMPSON & E.M. SHEVACH. 1995. B7/CD28 dependent and independent induction of CD40 ligand expression. J. Immunol. 155: 5124-5132.
7. GREWAL, I.S. & R.A. FLAVELL. 1996. The role of CD40 ligand in co stimulation and T cell activation. Immunol. Rev. 153: 85-106.
8. TESTI, R., D. D'AMBROSIO, R. DE MARIA & A. SANTONI 1994. The CD69 receptor: a multipurpose cell-surface trigger for haematopoietic cells. Immunol. Today 15: 479-483.
9. ATZENI, F., N. DEL PAPA, P. SARZI-PUTTINI, et al. 2004. CD69 expression on neutrophils from patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 22: 331-334.
10. GONZALEZ-AMARO, R., D. PORTALES-PEREZ, L. BARANDA, et al. 1998. Role ofIL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus. J. Autoimmun. 11: 395-402.
11. CRISPIN, J.C., A. MARTINEZ, P. DE PABLO, et al. 1998. Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand. J. Immunol. 2: 196-200.
12. MOSZKORZOVA, L., Z. LACINOVA, J. MAREK, et al. 2002. Hyperprolactinaemia in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 20: 807-812.
13. BLANCO-FAVELA, F., G. QUINTAL-ALVAREZ & A. LEAÑOS-MIRANDA. Association between prolactin and disease activity in SLE. Influence of statistical power. J. Rheumatol. 26: 55-59.
14. LAVALLE, C., E. LOYO & R. PANIAGUA 1987. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J. Rheumatol. 14: 268-272.
15. JARA, L.J., C. GOMEZ-SANCHEZ, L.H. SILVEIRA, et al. 1992. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am. J. Med. Sci. 303: 222-226.
16. BUSKILA, D., M. LORBER, L. NEUMANN, et al. 1996. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J. Rheumatol. 23: 629-632.
17. PAUZNER, R., M.B. UROWITZ, D.D. GLADMAN & J.M. GOUGH 1994. Prolactin in systemic lupus erythematosus. J. Rheumatol. 21: 2064-2067.
18. NEIDHART, M. 1996. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J. Rheumatol. 23: 476-481.
19. OSTENDORF, B., R. FISCHER, R. SANTEN, et al. 1996. Hyperprolactinemia in systemic lupus erythematosus? Scand. J. Rheumatol. 25: 97-102.
20. BUSKILA, D., M. BEREZIN, H. GUR, et al. 1995. Autoantibody profile in the sera of women with hyperprolactinemia. J. Autoimmun. 8: 415-424.
21. RUIZ-IRASTORGA, G., F. LIMA, J. ALVES, et al. 1996. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies. Br. J. Rheumatol. 35: 133-138.
22. FOLOMEEV, M., T. PROKAEVA & V. NASSONOVA. 1990. Prolactin levels in men with SLE and RA. J. Rheumatol. 17: 1569-1570.
23. MCMURRAY, R., D. KEISLER, K. KANUEKEL, et al. 1991. Prolactin influences autoimmune disease activity in the female B/W mouse. J. Immunol. 147: 780-787.
24. MCMURRAY, R., D. KEISLER, S. IZUOI & S.E. WALKER. 1994 Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone. Clin. Immunol. Immunopathol. 71: 338-343.
25. BERTON, E.W., M.S. MELTZER & J.W. HOLADAY. 1988. Suppression of macrophage activation and T lymphocyte function in hypoprolactinemic mice. Science 239: 401-404.
26. CLEVENGER, C.V., D.O. FREIER & J.B. KLINE. 1998. Prolactin receptor signal transduction in cell of the immune system. J. Endocrinol. 157: 187-197.
27. RUSSEL, D.H., L. MATRISIAN, R. KIMBLER, et al. 1984. Prolactin receptor on human lymphocytes and their modulation by cyclosporine. Biochem. Biophys. Res. Co. 121: 899-906.
28. CLEVENGER, C.V., D.H. RUSSEL, P.M. APPASANY & M.B. PRYTOWKY. 1990. Regulation of IL-2 driven T lymphocyte proliferation by prolactin. Proc. Nat. Acad. Sci. USA. 87: 6460-6464.
29. HARTMANN, D.P., J.W. HOLODAY & E.W. BERTON. 1989. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB 3: 2194-2202.
30. MATERA, L., A. CESANO, G. BELLONE & E. OBERHOLTZER. 1992. Modulatory effect of prolactin on the resting and mitogen induced activity of T, B and NK lymphocyte. Brain Behav. Immun. 6: 409-417.
31. LEAÑOS-MIRANDA, A., D. PASCOE- LIRA, K. CHAVEZ-RUEDA & F. BLANCO-FAVELA. 2001. Anti-prolactin antibodies in systemic lupus erythematosus patients; frequency and correlation with prolactinemia and disease activity. J. Rheumatol. 7: 1546-1553.
32. BLANCO-FAVELA, F., M.A.G. QUINTAL, K. CHAVEZ-RUEDA, et al. 2001. Antiprolactin autoantibodies in pediatric systemic lupus erithematosus patients. Lupus 11: 803-808.
33. BERCZI, I., E. NAGY, K. KOVACS & E. HORVATH. 1981. Regulation of humoral immunity in rat by pituitary hormone. Acta Endocrinol. 98: 506-513.
34. LI, J., W. TENG & Z. SHAN. 2001. Effect of prolactin on HLA-DR and CD40 expressions by human thyrocytes. Chin. Med. J. 114: 1151-1156.
35. HORSEMAN, N.D., W. ZHAO, E. MONTECINOS-RODRIGUEZ, et al. 1997. Defective mammopoiesis, but normal haematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO 16: 6926-6935.
36. CHAVEZ-RUEDA, K., J. HERNANDEZ, E. ZENTENO, et al. 2005. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin. Immunol. 116: 182-191.